Drug Use Investigation Of Effexor (SECONDARY DATA COLLECTION STUDY; SAFETY AND EFFICACY OF EFFEXOR.UNDER JAPANESE MEDICAL PRACTICE)

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1408 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-10-03

Study Completion Date

2020-05-11

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

SECONDARY DATA COLLECTION STUDY; SAFETY AND EFFICACY OF EFFEXOR.UNDER JAPANESE MEDICAL PRACTICE

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

NCT01441440

Major Depressive Disorder

COMPLETED PHASE3

Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)

NCT01485887

Major Depressive Disorder

COMPLETED PHASE3

Study Evaluating Effexor® (Venlafaxine) in Achieving Response and Maintaining Remission

NCT00546494

Depression

COMPLETED PHASE4

Effectiveness of the Dual Serotonin Norepinephrine Reuptake Inhibitor Desvenlafaxine Succinate in Healthy Volunteers

NCT01101152

Healthy

UNKNOWN PHASE1

Serotonin Effect in Functional Dyspepsia

NCT00115362

Dyspepsia

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study will be conducted under the central registration system until the number of subjects who meet the conditions for registration reaches the target number of subjects. 12 weeks from the start date. The patients who completed the 12-week treatment with this product will be observed up until Week 52.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Depression/Depressed State

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

venlafaxine

Patients with no experience of using time Effexor(venlafaxine) who will be administered time Effexor(venlafaxine)for the first

venlafaxine

Intervention Type DRUG

The usual adult starting dosage for oral use is 37.5 mg of venlafaxine once daily, which is increased to 75 mg once daily after a meal from 1 week later. The dose may be adjusted within a range not exceeding 225 mg/day according to the patient's age and symptoms. However, the dose should be increased by 75 mg/day at intervals of not less than 1 week.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

venlafaxine

The usual adult starting dosage for oral use is 37.5 mg of venlafaxine once daily, which is increased to 75 mg once daily after a meal from 1 week later. The dose may be adjusted within a range not exceeding 225 mg/day according to the patient's age and symptoms. However, the dose should be increased by 75 mg/day at intervals of not less than 1 week.

Intervention Type DRUG